KR101849662B1 - Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea - Google Patents
Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea Download PDFInfo
- Publication number
- KR101849662B1 KR101849662B1 KR1020160160097A KR20160160097A KR101849662B1 KR 101849662 B1 KR101849662 B1 KR 101849662B1 KR 1020160160097 A KR1020160160097 A KR 1020160160097A KR 20160160097 A KR20160160097 A KR 20160160097A KR 101849662 B1 KR101849662 B1 KR 101849662B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- alcohol
- hangover
- prevention
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 230000002265 prevention Effects 0.000 title claims abstract description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 title abstract description 4
- 244000234609 Portulaca oleracea Species 0.000 title abstract description 4
- 206010001623 Alcoholic hangover Diseases 0.000 title 1
- 206010019133 Hangover Diseases 0.000 claims abstract description 28
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 21
- 229940098324 green tea leaf extract Drugs 0.000 claims abstract description 12
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 19
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims description 11
- 229940051810 licorice root extract Drugs 0.000 claims description 11
- 235000020725 licorice root extract Nutrition 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims 1
- 229960001285 quercetin Drugs 0.000 claims 1
- 235000005875 quercetin Nutrition 0.000 claims 1
- 239000002075 main ingredient Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract description 2
- 235000000039 Opuntia compressa Nutrition 0.000 abstract description 2
- 241000454613 Opuntia humifusa Species 0.000 abstract description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 abstract description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 1
- 244000010000 Hovenia dulcis Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 235000019441 ethanol Nutrition 0.000 description 38
- 239000011521 glass Substances 0.000 description 20
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000035622 drinking Effects 0.000 description 11
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000202807 Glycyrrhiza Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000008030 elimination Effects 0.000 description 6
- 238000003379 elimination reaction Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940008396 carrot extract Drugs 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229940010454 licorice Drugs 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 3
- 235000021374 legumes Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 2
- 241000219357 Cactaceae Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- -1 diphenyl-1picryl hydrazyl Chemical group 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229940116257 pepper extract Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 229930182836 (R)-noradrenaline Natural products 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 240000002132 Beaucarnea recurvata Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000405398 Hovenia Species 0.000 description 1
- 235000008586 Hovenia Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000985630 Lota lota Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000000405 Pinus densiflora Nutrition 0.000 description 1
- 240000008670 Pinus densiflora Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- ADRDEXBBJTUCND-UHFFFAOYSA-N pyrrolizidine Chemical compound C1CCN2CCCC21 ADRDEXBBJTUCND-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940030961 sorghum extract Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 숙취 예방 및 해소용 생약 조성물에 관한 것으로서, 더욱 상세하게 설명하자면, 쇠비름 추출물을 주성분으로 하고 여기에 스테비아잎 추출물, 지구자(枳子) 추출물, 천년초 추출물, 녹차잎 추출물 및 감초뿌리 추출물이 혼합되어 이루어지는 숙취 예방 및 해소용 생약 조성물에 관한 것이다.The present invention relates to a herbal composition for prevention and resolution of hangover, and more particularly, to a herbal composition for prevention and elimination of hangover, which comprises as an active ingredient a carnauba wax extract as a main component, a stevia leaf extract, a 枳 子 extract, a quinquinone extract, a green tea leaf extract and a licorice root extract To a herbal composition for prevention and resolution of hangover.
술의 주성분인 알코올은 입속의 점막으로부터 장에 이르기까지 다양한 경로로 흡수되지만, 주로 위와 소장에서 흡수된다. 인체가 과량의 알코올을 흡수하면 중추신경계가 마비되면서 외관상 흥분한 상태를 보이지만, 적당량의 알코올은 수면을 유도하고 마취 효과를 나타내기도 한다. 그래서 적당한 음주는 사회활동에서 오는 스트레스를 해소하고, 긴장감을 줄여 주는 역할도 하며, 경우에 따라서는 약주라고 하여 건강에 도움을 주기도 한다. Alcohol, the main component of alcohol, is absorbed by various pathways from the mucous membrane of the mouth to the intestine, but is mainly absorbed in the stomach and small intestine. If the body absorbs excess alcohol, the central nervous system becomes paralyzed and appears to be excited. However, an appropriate amount of alcohol may induce sleeping and an anesthetic effect. Therefore, proper drinking can relieve stress from social activities, reduce tension, and in some cases, it helps to improve health.
음주 후 위 장관에서 흡수된 알코올은 혈류를 통해 뇌와 간을 포함한 신체 각 조직으로 분포된다. 그리고 간세포에서는 알코올 탈수소 효소(ADH; alcohol dehydrogenase)에 의해 알코올이 산화되어 아세트알데히드가 되고, 상기 아세트알데히드는 아세트알데히드 탈수소 효소(ALDH; acetaldehyde dehydrogenase)에 의해 아세트산으로 분해된 다음, 전신의 근육이나 지방 조직으로 분산되어 최종적으로 탄산가스와 물로 분해된다. Alcohol absorbed from the gastrointestinal tract after drinking is distributed throughout the body, including the brain and liver, through the bloodstream. In hepatocytes, alcohol is oxidized by alcohol dehydrogenase (ADH) to become acetaldehyde. The acetaldehyde is decomposed into acetic acid by acetaldehyde dehydrogenase (ALDH), and then the whole body muscle or fat And finally decomposed into carbon dioxide and water.
알코올은 음주량이나 혈중 농도에 관계없이 매 시간당 일정량씩만 대사되는데, 이러한 알코올의 대사에 관여하는 효소의 역가나 농도는 각 개인의 유전적 특성이나 환경적인 요인에 의해 결정되며, 각 개인의 성별, 연령, 체중, 영양 상태 및 신체 조건에 따라 영향을 받는다. 그리고 알코올의 대사 과정에서 생성되는 아세트 알데히드는 일시적으로 갈증, 피로감, 기억상실, 두근거림, 두통, 홍조, 구토, 위장장애, 설사 등의 숙취 현상을 유발한다. Alcohol is metabolized only a certain amount of time per hour regardless of the amount of alcohol or blood concentration. The inverse of the enzyme involved in the metabolism of alcohol is determined by the genetic and environmental factors of each individual. , Weight, nutritional status, and physical condition. Acetaldehyde, which is produced during the metabolism of alcohol, temporarily causes a hangover such as thirst, fatigue, amnesia, throbbing, headache, flushing, vomiting, gastrointestinal disorder and diarrhea.
음주로 인한 숙취 문제를 해결하기 위하여, 최근 알코올 및 알코올 대사물의 독성을 경감시키거나 독성의 발현을 저해하는 방법으로 알코올이 인체에 미치는 영향을 최소화할 수 있는 숙취 해소용 생약 조성물의 개발이 활발히 이루어져 왔다. 그러나 종래 생약 조성물의 숙취 예방 및 해소의 효능은 여전히 만족스럽지 못한 실정이며, 특히 사람마다 알코올 대사에 관여하는 요인들이 상이하기 때문에 각 개인의 체질에 맞는 새로운 생약 조성물의 개발이 지속적으로 요구되고 있다.In order to solve the hangover problem caused by drinking alcohol, there has been actively developed a herbal composition for hangover resolution which can minimize the influence of alcohol on the human body by reducing the toxicity of alcohol and alcohol metabolites or inhibiting the expression of toxicity come. However, the efficacy of preventing and resolving the hangover of conventional herbal compositions is still unsatisfactory. In particular, since factors involved in alcohol metabolism are different for each person, development of a new herbal composition suitable for the individual constitution is continuously required.
한편, 쇠비름은 우리나라 전국 각지의 산기슭 밭이나 길가 빈터 등에 흔히 자라는 한해살이 풀로써, 한방에서는 쇠비름을 해독, 창종, 편도선염, 이뇨 등의 약재로 사용하고 있으며, 이러한 쇠비름의 효능을 이용한 특허도 다수 출원되어 있다. 예를 들어 대한민국 등록특허 제10-0442683호(2004년 07월 22일)에는, 쇠비름 열수 추출물을 주재료로 하고, 부재료로 감초, 생강, 대추, 박하 열수 추출물이 함유되는 것을 특징으로 하는 항암 및 항균 효과가 있는 쇠비름 음료가 소개되어 있고, 공개특허 제10-2014-0052619호(2014년 05월 07일)에는 쇠비름 추출액과 모로미초를 주성분으로 하고, 항균, 항염증, 항암, 항노화, 항비만 효과를 갖는 식품 조성물이 소개되어 있으며, 등록특허 제10-1426501호(2014년 07월 29일)에는 쇠비름과 미강을 주성분으로 하고, 소화력 향상, 피부 개선, 저항성 증진, 저체중 개선 및 변비해소 기능을 갖는 발효 조성물이 소개되어 있다. On the other hand, Purslane is an annual plant which grows frequently in mountainous fields and roadside pavilions around the country, and is used as medicines such as detoxification, angelica, tonsilitis and diuretic in legumes. have. For example, Korean Patent No. 10-0442683 (Jul. 22, 2004) discloses an anticancer and antimicrobial agent which is characterized in that the main ingredient is dried bean curd hot water, and the ingredients include licorice, ginger, jujube, (May 07, 2014), which is based on olive oil extract and moromicho, and has antimicrobial, anti-inflammatory, anti-cancer, anti-aging, anti-obesity (July 29, 2014), the main component is carnauba and rice bran, and it has improved the digestive power, improved skin, improved resistance, reduced weight gain and relieved constipation. Have been introduced.
이외에도 숙취 해소와 관련하여 등록특허 제10-1524373호(2015년 05월 22일)에는, (a)칡뿌리 추출물 100 중량부를 기준으로 30~80 중량부의 쑥잎 추출물, 10~50 중량부의 솔잎 추출물, 5~20 중량부의 쇠비름 추출물, 5~20 중량부의 칡꽃 추출물, 5~20 중량부의 인동 추출물 및 5~20 중량부의 감초 추출물을 포함하는 혼합약재 추출물 5~20 중량%; (b) 감미료(甘味料) 및 조미료(調味料) 5~20 중량%; 및 (c) 잔량의 정제수로 이루어지는 숙취 해소용 음료 조성물이 소개되어 있다.In addition, in the case of hangover relief, in Registration No. 10-1524373 (May 22, 2015), 30 to 80 parts by weight of mugwort leaf extract, 10 to 50 parts by weight of pine needles extract, 5 to 20% by weight of a mixed medicinal extract comprising 5 to 20 parts by weight of glycyrrhiza extract, 5 to 20 parts by weight of a chrysanthemum extract, 5 to 20 parts by weight of an indigo extract and 5 to 20 parts by weight of a licorice extract; (b) 5 to 20% by weight of a sweetener and a seasoning; And (c) a purified water of the remaining amount.
이 중에서 상기 숙취 해소용 음료 조성물의 경우, 쇠비름 추출물을 포함하기는 하지만, 주원료는 칡뿌리 추출물이고 상기 쇠비름 추출물은 6가지 보조원료 중 하나로서 그 함량이 청구범위 기준으로 상기 조성물 총 중량의 0.16~1.29 중량%(실시예 1 및 실시예 6의 경우 0.42 중량%)에 불과하기 때문에 상기 쇠비름의 숙취 효능을 거의 살리지 못하고 있다. Among them, the hangover-removing beverage composition contains the extract of Aspergillus oryzae, but the main ingredient is the extract of Aspergillus oryzae and the extract of Aspergillus oryzae is one of the six kinds of auxiliary materials, 1.29% by weight (0.42% by weight in the case of Example 1 and Example 6), so that the hangover effect of the ponytail is hardly utilized.
앞서 살핀 바와 같이, 쇠비름은 생리학적으로 다양한 효능이 있어서 종래에도 민간요법 생약제로서 꾸준히 사용되어 왔다. 이에 본 발명자들은 쇠비름의 효능 중에서 항산화 효능에 주목하며 연구를 거듭한 결과, 쇠비름 추출물이 숙취의 예방 및 해소에도 탁월한 효과가 있다는 사실을 발견하여 본 발명에 이르게 되었다. As we have seen, legume has been used as a folk remedy in the past because of its physiologically diverse efficacy. Accordingly, the inventors of the present invention have focused on antioxidant efficacy in the effectiveness of Peppermint, and as a result, found that Peppermint Extract has an excellent effect on prevention and elimination of hangover, leading to the present invention.
이에 본 발명의 목적은 쇠비름 추출물을 주성분으로 하는 숙취 예방 및 해소용 생약 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a herbal composition for preventing and eliminating hangovers, which comprises a carnauba wax extract as a main component.
본 발명에 따른 숙취 예방 및 해소용 생약 조성물은, 쇠비름 추출물을 주성분으로 하고, 여기에 스테비아잎 추출물, 지구자(枳子) 추출물, 천년초 추출물, 녹차잎 추출물 및 감초뿌리 추출물을 포함하는 것을 특징으로 한다.The herbal composition for preventing and eliminating hangover according to the present invention is characterized in that it contains chrysanthemum chrysanthemum extract as a main component and the extract includes Stevia leaf extract, Chrysanthemum chrysanthemum extract, Chenille seed extract, Green tea leaf extract and Licorice root extract do.
본 발명에 따른 숙취 예방 및 해소용 생약 조성물은, 쇠비름 추출물 100 중량부에 대하여, 스테비아잎 추출물 7~40 중량부, 지구자(枳子) 추출물 4~25 중량부, 천년초 추출물 7~25 중량부, 녹차잎 추출물 1~10 중량부 및 감초뿌리 추출물 1~3 중량부를 포함하는 것을 특징으로 한다.The herbal composition for preventing and eliminating hangover according to the present invention comprises 7 to 40 parts by weight of a Stevia leaf extract, 4 to 25 parts by weight of an extract of Stevia leaf, 7 to 25 parts by weight 1 to 10 parts by weight of green tea leaf extract, and 1 to 3 parts by weight of licorice root extract.
본 발명에 따른 숙취 예방 및 해소용 생약 조성물은, 음주 전후에 복용하면 체내 알코올을 신속하게 분해하여 혈중 알코올 농도를 신속하게 저하시키고, 특히 알코올 대사과정에서 발생하는 아세트 알데하이드를 빠르게 대사시켜서 음주로 인한 숙취 현상을 효율적으로 예방 및 해소하는 효과가 있다. The herbal composition for prevention and elimination of hangovers according to the present invention can rapidly decompose the alcohol in the body by taking the alcohol before and after drinking, rapidly lowering the blood alcohol concentration and rapidly metabolizing the acetaldehyde generated in the alcohol metabolism, There is an effect of effectively preventing and eliminating the hangover phenomenon.
이하, 본 발명을 상세하게 설명하면 다음과 같다. 다만, 본 발명을 실시하는데 꼭 필요한 사항이라 하더라도, 공지 기술에 속하거나, 당업자가 통상의 기술로보터 용이하게 실시할 수 있는 사항에 대해서는 구체적인 설명을 생략한다.Hereinafter, the present invention will be described in detail. However, even if it is indispensable to carry out the present invention, the detailed description of the matters which belong to the known technology or which can be easily carried out by a person skilled in the art from the ordinary technology will be omitted.
먼저 본 발명에서 주성분인 쇠비름 추출물을 제조하는데 사용되는 생약재인 쇠비름(Portulaca oleracea L.)은 마치현 또는 돼지풀이라 불리는 한해살이 풀로써, <동의학사전> 에는 심경과 대장경에 작용하여 열을 내리고 독을 풀며 어혈을 없애고 오줌을 잘 누게 하는 효능이 있다고 기록되어 있으며, 민간요법으로는 충독, 사독 등에 대한 해독제로도 사용되고 있다.In the present invention, Portulaca oleracea L., a herbal medicine used to produce the main component of the pepper shrimp extract of the present invention, is an annual plant called Hachian or Pig paste, and acts on the heart and colon, It is said that it has the efficacy of eliminating the eosinophilia and urine, and it is also used as an antidote for poisoning and poisoning in folk remedies.
약리실험에 따르면, 쇠비름 추출물은 강심작용과 혈압을 높이는 작용, 억균작용, 자궁을 수축시키는 작용, 피를 멎게 하는 작용 등이 밝혀져 있으며, 대장염을 예방하는 효과도 있는 것으로 보고되어 있다. 쇠비름 추출물의 구성성분으로는 엘-노르아드레날린(L-noradrenaline), 도파민(dopamine), 도파(dopa) 등을 포함하고 있으며, 그 외 비타민 K와 많은 양의 유기산, 글루타민산(glutamic acid), 아스파르트산(aspartic acid), 알라닌(alanine) 등을 포함하고 있다. 또한, 쇠비름의 전초, 특히 잎이나 줄기에는 어류에 다량 함유되어 있는 감마 리놀렌산과 오메가-3- 불포화 지방산의 함량이 높은 것으로 보고되어 있다. According to the pharmacological experiments, the extracts of black pepper have been shown to have action to increase the blood pressure, to enhance the blood pressure, to inhibit the function of the uterus, to stop the blood, and to prevent colitis. The components of the pepper extract include L-noradrenaline, dopamine, dopa, and other vitamin K and a large amount of organic acid, glutamic acid, aspartic acid, aspartic acid, alanine, and the like. In addition, it is reported that the content of gamma linolenic acid and omega-3-unsaturated fatty acid, which are contained in fishes largely, are high in the outbreak of leggings, especially in leaves and stems.
최근 연구 보고서에 의하면, 쇠비름 추출물의 성분 중 가장 큰 비율을 차지하고 있는 플라본(flavone)은 항산화 효과가 뛰어나다고 보고되고 있으며, 스트레스를 유발하는 요인을 해소함으로써 노화방지 및 심장질환 예방에도 효과가 있어 의약품, 화장품 등 다양한 분야에 활용되고 있다. According to a recent research report, flavon, which is the largest component of the carrot extract, has been reported to excel in antioxidative effects and is effective in preventing aging and heart disease by eliminating factors that cause stress. , And cosmetics.
상기 쇠비름 추출물의 구성성분 중에서 특히 리놀렌산과 오메가-3-불포화 지방산은 알코올 탈수소 효소(alcohol dehydrogenase)에 대한 형성을 촉진하고, 상기 알코올 탈수소 효소가 간에서 알코올을 아세트 알데히드로 산화시키며, 상기 아세트 알데히드는 간 세포에 존재하는 아세트알데히드 탈수소 효소를 통해 초산으로 분해되는 과정을 통해서 숙취를 예방하고 나아가 숙취를 해소하는 효능을 나타낸다. 본 발명에서 상기 쇠비름 추출물의 함량은 기준 함량으로서 100 중량부를 포함한다.Particularly, linolenic acid and omega-3-unsaturated fatty acids accelerate the formation of alcohol dehydrogenase, and the alcohol dehydrogenase oxidizes alcohol to acetaldehyde in the liver, and the acetaldehyde The process of decomposition into acetic acid through acetaldehyde dehydrogenase, which is present in liver cells, shows the efficacy of preventing hangover and further relieving hangover. In the present invention, the content of the glycyrrhiza oil extract is 100 parts by weight as a reference content.
다음으로 스테비아(Stevia rebaudiana bertoni)는 국화과 식물로 파라과이 북동부 고산지대에 자생하는 식물로서, 특히 스테비아 잎에는 스테비오사이드(stevioside)와 레바우디오사이드(rebaudioside)와 같은 감미물질이 다량 함유되어 있다. 그래서 스테비아잎 추출물은 당 대체 감미제로서, 해산물, 피클, 디저트, 과자류 등 여러 식품에 다양하게 사용되고 있으며, 현대인들의 당뇨병, 비만, 고지혈증 및 충치 등의 예방에 도움을 주고(Toskulkao C 등 1997), 알러지 치료 효과도 있어서 의료용으로도 활용되고 있다. Stevia (Stevia rebaudiana bertoni) is a plant of Asteraceae that grows in the high mountains of northeastern Paraguay. Especially stevia leaf contains a large amount of sweet substance such as stevioside and rebaudioside. Therefore, Stevia leaf extract is a sugar substitute sweetener that is widely used in various foods such as seafood, pickles, desserts, and confectionary. It helps modern people to prevent diabetes, obesity, hyperlipidemia and cavities (Toskulkao C et al. 1997) It is also used for medical purposes because of its therapeutic effect.
상기 스테비아 잎 추출물은 열에 안정적이어서 120℃에서 1시간 가열 후에도 pH나 단맛을 그대로 유지되며, 그동안 독성에 대해서도 광범위하게 연구되어 왔으나, 포유류에서는 발암성과 유전독성을 포함하여 어떤 독성도 관찰되지 않았다(Koyama E 등 2003). The stevia leaf extract is stable to heat and maintains its pH and sweet taste even after heating at 120 ° C for 1 hour. In the meantime, toxicity has been extensively studied. However, no toxicity was observed in mammals including carcinogenicity and genotoxicity (Koyama E et al. 2003).
본 발명에서 스테비아 잎 추출물은 감미제로서 상기 쇠비름 추출물에서 나타나는 특유의 쓴맛, 짠맛 및 다른 생약 성분들의 바람직하지 않은 맛을 마스킹(masking) 하여 복용의 편의성을 개선해 주는 기능을 한다.In the present invention, the Stevia leaf extract has a function of improving convenience of taking by masking an unpleasant taste of the bitter taste, salty taste and other herbal ingredients, which appear in the pepper extract as a sweetener.
상기 스테비아 잎 추출물의 함량은 상기 쇠비름 추출물 100 중량부에 대하여 7~40 중량부를 포함하는데, 상기 함량이 7 중량부 미만이면 다른 생약 성분들의 바람직하지 않은 맛을 충분히 마스킹(masking) 하지 못하여 복용의 편의성이 저하되는 문제가 있고, 반대로 40 중량부를 초과하면 상대적으로 상기 쇠비름 추출물을 비롯한 다른 생약 성분들의 함량이 낮아져서 숙취의 예방 및 해소 효과가 낮아지는 문제가 있다.The content of the stevia leaf extract is 7 to 40 parts by weight based on 100 parts by weight of the carrot extract. If the content of the stevia leaf extract is less than 7 parts by weight, the undesirable taste of other herbal ingredients can not be masked sufficiently, . On the contrary, when the amount of the active ingredient is more than 40 parts by weight, the content of other herbal medicine ingredients such as the glycyrrhiza extract is lowered, and the effect of preventing and solving hangover is lowered.
상기 지구자(枳子)는 헛개나무의 열매이다. 헛개나무는 갈매나무과(Rhamnaceae)의 낙엽 교목으로서, ‘지구자 나무’라고도 하며, 한국, 일본, 중국 등에 분포되어 있고, 깊은 산이나 높은 산까지 양지 쪽에 주로 서식한다. 헛개나무의 열매, 즉 지구자는 갈색이 돌고 지름은 약 8mm 정도이며 닭의 발톱 모양으로, 열매의 3실에 각각 1개씩의 종자가 들어 있다. The above-mentioned geonja (枳 子) is a fruit of a hinoki tree. Hovenia is a deciduous tree of Rhamnaceae. It is also called a "tree tree" and is distributed in Korea, Japan, and China. The fruit of the hinoki tree, that is, the globe, is brown with a diameter of about 8mm. It is shaped like a chicken's claw.
지구자는 익을 무렵이면 과경이 굵어져서 울퉁 불통하게 되고, 은은한 향기와 단맛이 있어 먹을 수 있으며, 음식 맛을 한결 돋우는 역할을 한다. 또한, 지구자 추출물은 숙취 해소에 뛰어난 효능이 있으며, 특히 술에 의해 상한 위, 간, 폐 대장 등를 치료하고, 가슴 속의 열과 갈증을 해소하며, 구토 완화, 이뇨 작용, 변비 치료 및 오장을 조화롭게 하는 작용을 하는 것으로 알려져 있다. 상기 지구자 추출물의 구성성분들 중에서 특히 암페롭신(ampelopsin)과 호베니틴스(hovenitins)이 음주자의 간 세포를 보호하는 작용을 한다. At the time of the ripening, the planet becomes thicker and thicker, and has a fragrant smell and a sweet taste. It plays a role of enhancing the taste of food. In addition, the Zygote extract has excellent efficacy in hangover relief, especially in the treatment of upper gastrointestinal, liver, and lung colon by alcohol, relieving heat and thirst in the chest, alleviating vomiting, diuretic, It is known to work. Ampelopsin and hovenitins, among the constituents of the endemic extract, protect the liver cells of the drinker.
상기 지구자 추출물의 함량은 상기 쇠비름 추출물 100 중량부에 대하여 4~25 중량부를 포함한다. 만일 상기 지구자 추출물의 함량이 4 중량부 미만이면 상기 암페롭신과 호베니틴스의 함량이 떨어져서 간세포 보호 작용이 저하되는 문제가 있고, 반대로 25 중량부를 초과하면 피롤리지딘이라는 알칼로이드 성분의 함량이 높아져서 간에 나쁜 영향을 미칠 우려가 있다.The content of the mitochondria extract is 4 to 25 parts by weight based on 100 parts by weight of the extract. If the amount of the kidney extract is less than 4 parts by weight, the content of amperopine and hobenitintes is lowered to lower the protective function of the hepatocyte. On the other hand, if the content of the kidney extract is more than 25 parts by weight, the content of the alkaloid component called pyrrolizidine increases There is a risk of adversely affecting the liver.
다음으로 천년초(Opuntia humifusa)는 선인장과에 속하는 식물로, 특히 지중해 및 중미 지방에 널리 분포되어 있으며, 생화학적 특성이 잘 규명되어 있다. 천년초의 줄기에는 다른 선인장들에 비하여 폴리페놀(polyphenols) 및 플라보노이드(flavonoid)가 다량 함유되어 있으며, DPPH 라디칼(diphenyl-1picryl hydrazyl)에 대한 항산화 및 소거 활성을 갖고 있다. Next, Opuntia humifusa is a plant belonging to the genus Cactus and is widely distributed in the Mediterranean and Central America, and its biochemical characteristics are well known. The stem of Cheonnyuncho contains a large amount of polyphenols and flavonoids compared to other cacti, and has antioxidant and scavenging activity against DPPH radical (diphenyl-1picryl hydrazyl).
또한 천년초 추출물은 스트렙토조토신-유도(sereptozotocin-induced) 당뇨병 마우스에서 염증반응 촉진 사이토카인 발현을 조절하고, 저혈당 및 저지질 활성을 갖는 것으로 알려져 있다. 특히 상기 천년초 추출물에는 플라보노이드, 비타민 C, 아미노산, 칼슘 및 식이섬유 등이 다량 함유 되어 있는데 그중에서 비타민 C는 간에서 알코올의 대사산물인 아세트 알데하이드가 생성 되는 것을 억제하는 기능을 한다. In addition, it has been known that Chenilleae extract has a hypoglycemic and hypolipidemic activity and regulates inflammatory response-promoting cytokine expression in sereptozotocin-induced diabetic mice. In particular, vitamin C contains a large amount of flavonoids, vitamin C, amino acids, calcium, and dietary fiber. The vitamin C inhibits the production of acetaldehyde, which is a metabolite of alcohol, in the liver.
상기 천연초 추출물의 함량은 상기 쇠비름 추출물 100 중량부에 대하여 7~25 중량부를 포함한다. 만일 상기 천연초 추출물의 함량이 7 중량부 미만이면 유효 성분의 추출이 곤란한 있는 문제가 있고, 반대로 25 중량부를 초과하면 천년초 특유의 점액질 물성의 증가로 인해서 음용 시 복용자에게 불쾌감을 유발할 수 있고, 나아가 페르펜 성분 등의 함량이 증가하여 다소 거북한 맛이 날 우려가 있다.The content of the natural herbal extract is 7 to 25 parts by weight based on 100 parts by weight of the carrot extract. If the content of the natural herbal extract is less than 7 parts by weight, extraction of the active ingredient is difficult. On the other hand, if the content of the natural herbal extract is more than 25 parts by weight, it may cause discomfort to the user, The content of the perphene component and the like may increase, which may cause a somewhat rough taste.
차나무(Camellia sinensis)는 원산지가 중국으로 차나무 후피향 나무과에 속하는 상록 활엽 관목으로, 잎의 크기와 모양, 채취시기 등에 따라 이름도, 품질도 다양하다. 차나무는 심은 지 3년 이상 되면 잎을 딸 수 있고, 차나무 잎의 추출물은 고대 중국에서부터 마시기 시작한 것으로 알려진 녹차(綠茶)이다. Camellia sinensis is an evergreen broad-leaved shrub belonging to the Pinus densiflora after the tea plantation in China, and its name and quality vary according to the size and shape of the leaf and the time of collection. Tea leaves can be harvested more than three years after planting, and the extract of tea leaves is green tea (綠茶), which is known to have begun drinking from ancient China.
녹차잎 추출물의 주요성분으로는 카페인, 탄닌, 테아닌, 세키세놀, 비타민 C, 비타민 B1, B2, 나이아신, 펜토텐산, 이노시톨, 루틴 등이 알려져 있다. 그리고 녹차잎 추출물에는 카테킨(catechin)이라 불리우는 탄닌 성분이 들어 있어서 쌉싸름한 맛을 낸다. 폴리페놀의 한 종류인 카테킨은 항산화 작용을 하며, 그중 가장 강력한 성분인 EGCG는 비타민 C 보다 항산화 효능이 20배 정도나 높은 것으로 알려져 있다. The main ingredients of green tea leaf extract are caffeine, tannin, theanine, siccenol, vitamin C, vitamin B1, B2, niacin, pentotenic acid, inositol, and rutin. And green tea leaf extract contains a tannin ingredient called catechin, which gives a bland taste. Catechin, a type of polyphenol, has antioxidant activity, and EGCG, which is the most potent component of catechin, is known to have antioxidant activity 20 times higher than vitamin C.
상기 녹차잎 추출물은 주요 구성성분인 카테킨이 혈중 알코올 농도를 저하시키는 작용이 있으며, 그 함량은 상기 쇠비름 추출물 100 중량부에 대하여 1~10 중량부를 포함한다. 만일 상기 녹차잎 추출물의 함량이 1 중량부 미만이면 위 및 간 보호 효과가 미미하고, 반대로 10 중량부를 초과하면 사용량 증가에 따른 상승효과가 거의 없어서 바람직하지 않다.The green tea leaf extract has a function of lowering the blood alcohol concentration by the main component catechin, and the content thereof is 1 to 10 parts by weight based on 100 parts by weight of the carrot extract. If the content of the green tea leaf extract is less than 1 part by weight, the effect of protecting the stomach and the liver is insignificant. On the other hand, if the content is more than 10 parts by weight, the synergistic effect of increasing the amount of green tea leaves is not preferable.
감초(Glycyrrhiza uralensis Fisch)는 콩과(Fabaceae)의 여러 해살이 풀로서 천연의 감미로운 맛과 다양한 약리적 특성을 가지고 있어서 예로부터 한약 재료로 많이 사용되어 왔다. 최근에는 감초에 대한 효능 및 효과가 인지되면서 기능성 식품이나 한방 화장품 등의 재료로 개발되어 그 수요가 매년 증가하고 있다. 감초뿌리에 함유된 대표적인 성분의 하나인 글리시리진(glycyrrhizin)은 천연의 감미제로서, 설탕의 약 50배 정도의 단맛을 내는데 강한 감미제 외에 진해 거담제 등으로도 사용되고 있다. Licorice (Glycyrrhiza uralensis Fisch) is a perennial plant of soybean (Fabaceae), which has a natural sweet taste and various pharmacological properties. In recent years, the efficacy and efficacy of licorice has been recognized, and it has been developed as a functional food or a herbal cosmetics, and the demand is increasing every year. Glycyrrhizin, one of the representative ingredients in licorice roots, is a natural sweetener. It is also used as an antioxidant, in addition to strong sweetening agents, which produce about 50 times the sweetness of sugar.
한의학에서는 감초뿌리 추출물의 생리활성 작용으로 항염 작용, 해독 작용, 항암 작용, 항산화 작용이 알려져 있고, 한방 화장품에서는 멜라닌 형성 억제작용 등이 있는 것으로 알려져 있다. 또한 임상적으로 감초뿌리 추출물은 통증과 경련을 완화 하고 신경의 긴장을 환화시켜주는 약재로, 또한 간장 질환이나 알레르기 질환 등의 치료 및 항궤양제, 건위 소화제로서도 널리 사용되고 있다. In Oriental medicine, the physiological activity of licorice root extract is known to have anti-inflammatory, detoxifying, anticancer and antioxidant effects, and melanin formation inhibitory action in oriental cosmetics. In addition, clinically, licorice root extract is a medicinal agent that alleviates pain and convulsions and circulates the tension of nerves, and is also widely used as a treatment for liver diseases and allergic diseases, as an antiulcer agent, and as a dry digestive agent.
이외에도 상기 감초뿌리 추출물에는 다양한 해독작용을 나타내는 글리시리진이 함유되어 있어서 간의 해독작용을 도와주는 기능을 하며, 그 함량은 상기 쇠비름 추출물 100 중량부에 대하여 1~3 중량부 인 것이 바람직하다. 만일 상기 감초뿌리 추출물의 함량이 1 중량부 미만이면 감초의 단맛과 유기산 등 유효 성분의 추출이 곤란한 문제가 있고, 반대로 3 중량부를 초과하면 식물 특유의 풀냄새가 나타나서 기호성이 감소하는 문제가 있다.In addition, the licorice root extract contains glycyrrhizin which exhibits a variety of detoxifying functions and functions to aid liver detoxification. The content of the glycyrrhizin is preferably 1 to 3 parts by weight per 100 parts by weight of the extract. If the content of the licorice root extract is less than 1 part by weight, there is a problem that it is difficult to extract the sweetness of the licorice and the active ingredient such as organic acid. On the other hand, if the content exceeds 3 parts by weight, there is a problem that the palatability of the plant is reduced.
본 발명에서 상기 생약 추출물들은 각 해당 생약들, 즉 쇠비름과 스테비아잎, 지구자(枳子), 천년초, 녹차잎 및 감초뿌리를 각각 세척한 후 92~98℃, 바람직하기로는 95℃의 온도에서 2시간 동안 열수 추출하거나, 알코올 함량이 30~95%인 발효 주정으로 추출한 다음, 여과하여 고형분을 제거하고 그 여액을 통상적인 방법으로 감압 농축하는 과정을 통해서 제조할 수 있다.In the present invention, the herbal medicine extracts are washed at a temperature of 92 to 98 ° C, preferably 95 ° C, after washing each of the herbal medicines, ie, black currant, stevia leaf, Extraction with hot water for 2 hours, extraction with a fermentation alcohol having an alcohol content of 30 to 95%, filtration to remove solid content, and concentration of the filtrate under reduced pressure in a conventional manner.
본 발명에 따른 숙취 예방 및 해소용 생약 조성물은, 이러한 방법으로 제조되는 6가지 생약 추출물, 즉 쇠비름 추출물과 스테비아잎 추출물, 지구자(枳子) 추출물, 천년초 추출물, 녹차잎 추출물 및 감초뿌리 추출물 만으로 구성될 수도 있고, 이들 생약 추출물 이외에 통상적인 첨가제로서 감미료나 산미료, 비타민류 등을 포함할 수도 있다. The herbal composition for prevention and elimination of hangover according to the present invention is characterized by containing only six herbal medicine extracts produced by this method, that is, carnauba wax extract, Stevia leaf extract, Zygoma extract, quinquinone extract, green tea leaf extract and licorice root extract In addition to these herbal medicine extracts, conventional additives may include sweeteners, acidifiers, vitamins and the like.
[ 실시예 ] 숙취 예방 및 해소용 생약 조성물의 제조[Example] Preparation of herbal composition for prevention and elimination of hangover
다음 표 1과 같은 구성성분 및 함량비로 각 생약 추출물과 기타 첨가제를 혼합하여 본 발명의 숙취 예방 및 해소용 생약 조성물을 제조 하였다.Each of herbal medicine extracts and other additives were mixed with the components and the contents ratios as shown in Table 1 below to prepare the herbal composition for prevention and resolution of hangover of the present invention.
상기 표 1에서, 액상과당은 ㈜대상의 75 Brix, 과당량 55% 이상인 제품을 사용 하였고, 효소처리 스테비아는 ㈜대경식품의 스테비안-50(효소처리 스테비아 100) 스테비올 배당체 80% 이상인 제품을 사용하였다. 또한, 산미료는 중국 WEIFANG ENSIGN INDUSTRY사의 구연산(결정)으로서 순도 99.5~105% 제품을 사용하였고, 비타민은 시판 중인 비타민 B1, B2, B6 및 C 제품을 사용하였다.In Table 1, the liquid fructose was 75 Brix and the swollen sugar content was 55% or more. Enzyme-treated stevia was used as a stevia-50 (enzyme-treated stevia 100) Respectively. In addition, 99% ~ 105% of pure acid was used as citric acid (crystal) of WEIFANG ENSIGN INDUSTRY in China, and vitamins used commercially available vitamins B1, B2, B6 and C were used.
[ 시험예 1 ] 관능 평가[Test Example 1] Sensory evaluation
상기 실시예 1~6의 생약 조성물에 대하여 전문가 3명이 5점 척도법으로 각각 맛과 향 및 색을 관능 평가하고, 그 결과를 다음 표 2 및 표 3에 수록하였다. 참고로 5점 척도법의 평가기준은‘5점: 매우 좋다’/‘4점: 약간 좋다’/‘3점: 보통이다’/‘2점: 약간 나쁘다’/‘1점: 매우 나쁘다’를 의미한다.For the herbal composition of Examples 1 to 6, three experts were subjected to sensory evaluation of taste, aroma and color by a five-point scale method, respectively, and the results are shown in Tables 2 and 3 below. For reference, the evaluation criteria of the 5-point scale method is "5 points: very good" / "4 points: slightly better" / "3 points: normal" / "2 points: slightly worse" / "1 point: very bad" do.
상기 표 2 및 표 3에서 보는 바와 같이, 상기 실시예 1~6의 생약 조성물 중에서 실시예 3의 생약 조성물에 대한 관능평가가 가장 우수한 것으로 나타났다.As shown in Tables 2 and 3, the herbal composition of Examples 1 to 6 showed the highest sensory evaluation for the herbal composition.
[ 시험예 2 ] 숙취 예방 및 해소에 대한 성능 측정[Test Example 2] Performance measurement for prevention and elimination of hangover
다음 표 4와 같이 10명의 피험자에게 각각 소정량의 알코올을 섭취하게 하되, 음주 전후에 각각 상기 실시예 3의 생약 조성물을 100ml 씩 복용하게 하고, 시간 경과에 따라 혈중 알코올 농도의 변화를 측정한 후 그 결과를 다음 표 4에 수록 하였다. As shown in the following Table 4, each of the 10 subjects was given a predetermined amount of alcohol, and 100 ml of the herbal composition of Example 3 was administered before and after drinking, and the change in blood alcohol concentration was measured over time The results are shown in Table 4 below.
각 피험자의 알코올 분해 능력이 서로 다른 점을 감안하여 개인별로 각각 다른 음주량을 설정하였고, 주종은 알코올 함량이 19%인 롯데칠성음료(주)의 제품명 ‘처음처럼’을 사용하였으며, 음주량은 40ml 짜리 술잔으로 계수하였다. 음주 시에 안주 등 다른 음식물은 섭취하지 않았으며, 음주 측정기는 ㈜센텍 코리아의 ‘Alcoscan AL5500’를 사용하였다.Considering the difference of alcohol decomposition ability of each subject, different amount of alcohol was set for each individual, and the main product was the product name of Lotte Chilsung beverage Co., which had an alcohol content of 19%, and the amount of alcohol was 40ml Respectively. Alcoscan AL5500 from Sentec Korea Co., Ltd. was used as a drinking instrument.
한편, 상기 표 4의 시험을 실시한 날로부터 3일 이 경과한 후에 상기 표 4와 동일한 피험자들에 대하여 동일한 양의 알코올을 섭취하게 하되, 이번에는 본 발명의 생약 조성물을 섭취하지 않고, 동일한 방법으로 혈중 알코올 농도를 측정하여 그 결과를 다음 표 5에 수록하였다.On the other hand, after 3 days had elapsed from the day of the test of Table 4, the same amount of alcohol as that of Table 4 was administered to the subjects, but this time, the herbal composition of the present invention was not taken, Blood alcohol concentration was measured and the results are shown in Table 5 below.
상기 표 4 및 표 5의 시험 결과로부터 확인되는 바와 같이, 음주 전후에 상기 실시예 3의 생약 조성물을 복용할 경우, 상기 생약 조성물을 복용하지 않은 대조군에 비해 음주 후 30분 경과시의 혈중 알코올 농도는 거의 유사하게 나타났지만, 1 시간 경과시에는 상기 생약 조성물을 섭취한 경우 평균 25% 정도의 혈중 알코올 농도 감소가 나타났으며, 2시간 경과시에는 상기 생약 조성물을 섭취한 경우 평균 35% 정도의 혈중 알코올 농도 감소가 나타났다. As can be seen from the test results shown in Tables 4 and 5, when the herbal composition of Example 3 was administered before and after drinking, the blood alcohol concentration at the time of 30 minutes after drinking was lower than that of the control group The average blood alcohol level was decreased by about 25% when the herbal composition was consumed at 1 hour, and when the herbal composition was consumed at 2 hours after the herbal composition was consumed, an average of about 35% Decrease in blood alcohol concentration appeared.
따라서, 본 발명의 생약 조성물은 음주 후 혈중 알코올을 신속하게 대사시켜서 숙취를 예방 및 해소하는 효능이 있는 것으로 확인되었다. Therefore, it has been confirmed that the herbal composition of the present invention has an effect of preventing and relieving hangover by rapidly metabolizing blood alcohol after drinking.
Claims (4)
5% by weight of quercetin extract, 4% by weight of green tea leaf extract, 1% by weight of licorice root extract, 11% by weight of liquid fructooligosaccharide, 0.038% by weight of an enzyme-treated Stevia, 0.38% by weight of an acidulant, 0.045% by weight of a vitamin, and 8.54% by weight of purified water.
4. The method according to claim 3, wherein the Stevia leaf extract, Zygomycorrhizae extract, Chenille seed extract, green tea leaf extract and licorice root extract are extracted with hot water at 95 ° C for 2 hours, And the herbal composition for prevention and resolution of hangover.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160160097A KR101849662B1 (en) | 2016-11-29 | 2016-11-29 | Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160160097A KR101849662B1 (en) | 2016-11-29 | 2016-11-29 | Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101849662B1 true KR101849662B1 (en) | 2018-04-18 |
Family
ID=62082605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160160097A KR101849662B1 (en) | 2016-11-29 | 2016-11-29 | Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101849662B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101524373B1 (en) * | 2013-12-09 | 2015-06-04 | 김재숙 | Beverage Composition for Treating Hangover |
-
2016
- 2016-11-29 KR KR1020160160097A patent/KR101849662B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101524373B1 (en) * | 2013-12-09 | 2015-06-04 | 김재숙 | Beverage Composition for Treating Hangover |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR101176590B1 (en) | Herbal Composition for Removing Hangover and Beverage Containing the Same | |
KR100372561B1 (en) | Compositions effective for removing hangover which contains natural herb tea extracts and health supplementing foods containing the same as an effective ingredient | |
KR101640591B1 (en) | Natural plant extracts fermentation coffee and manufacturing method thereof | |
KR100968109B1 (en) | Calcium?compound containing natural product composition for curing a hangover and preparation method thereof | |
KR20160087114A (en) | Food additive containing flowers | |
KR101953366B1 (en) | Functional Health Foods Comprising Aloeswood for Promoting Memory and Perceptivity and Preparation Methods Thereof | |
KR100552398B1 (en) | An alcohol detoxification beverage comprising extract of horse bean | |
KR101845388B1 (en) | Beverage composition with the extract of aged onion and the concentrate of wild genseng fruit | |
KR100315204B1 (en) | Onion juice fortified functionality and preparation thereof | |
KR101788253B1 (en) | Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic | |
KR101961356B1 (en) | Composition of Extract of Cirsium Japonicum and Manufacturing method thereof | |
KR100891914B1 (en) | The method of preparing the functional food for diet using extrative extrated from madicin-matrrials of plants | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR101849662B1 (en) | Herbal composition for prevention and relief of alcoholic hangover containing extract of portulaca oleracea | |
Nimbhorkar et al. | Caffeine alternatives: Seraching a herbal solution | |
CN108419869A (en) | Fiery composition, beverage and preparation method thereof under a kind of heat-clearing toxin expelling | |
KR102136053B1 (en) | Composition for Removing Hangover Comprising Herb Extract and Beverage Thereof | |
KR20040052930A (en) | Compounds for relief of alcoholic hangover and drug containing the compounds | |
CN110623103A (en) | Grosvenor momordica fruit and jasmine tea beverage capable of promoting production of body fluid to quench thirst and preparation method of beverage | |
KR101827874B1 (en) | Beverage composition with mixture extract of Cynanchum wilfordii, Angelica gigas and concentrate of wild ginseng fruit | |
KR0139381B1 (en) | Health drinks including green tea | |
KR20210115691A (en) | Composition for removing Hangover and health functional food comprising the same | |
KR20200142768A (en) | Composition for hangover cure conprising oriental herbal extract | |
KR101720927B1 (en) | A process for the preparation of functional beverage comprising balloon flower root and bamboo extracts and the functional beverages prepared therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |